New combo therapy aims to keep advanced lung cancer at bay
NCT ID NCT06810609
Summary
This study is testing a two-part treatment for stage III non-small cell lung cancer that can potentially be removed with surgery. First, patients receive a combination of chemotherapy and immunotherapy. Then, they are randomly assigned to either have surgery or receive chemoradiation (chemotherapy plus radiation). All patients then continue with a year of immunotherapy (durvalumab) to try to control the cancer and prevent it from coming back. The main goal is to see which treatment path keeps patients cancer-free for longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER NON-SMALL CELL CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johannes Wesling Klinikum Minden Mühlenkreiskliniken, Hämatologie und Onkologie
RECRUITINGMinden, North Rhine-Westphalia, 32429, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Klinikum Stuttgart
RECRUITINGStuttgart, Baden-Wurttemberg, 70174, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Bonn
RECRUITINGBonn, 53127, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Freiburg
RECRUITINGFreiburg im Breisgau, Baden-Wurttemberg, 79106, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Gießen
NOT_YET_RECRUITINGGiessen, Hesse, 35392, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.